Alembic Pharmaceuticals
NSEI:APLLTD Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
WA
Consensus Narrative from 12 Analysts
Future US Launches And GLP-1 Investments Will Strengthen Market Position
Key Takeaways Aggressive U.S. product launch strategy and peptide investments to counter price erosion and drive future high-margin revenue growth. Focus on domestic market optimization and strategic R&D expense reduction to improve net margins and earnings.
View narrative₹1.09k
FV
26.6% undervalued intrinsic discount11.41%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
12 days ago author updated this narrative